Incretin-Based Therapies Versus Bariatric and Metabolic Surgery for Obesity and Type 2 Diabetes Mellitus: A Head-to-Head Systematic Review of Glycaemic, Cardiovascular, Hepatic, Weight, and Quality-of-Life Outcomes. [PDF]
Alsayed O, Jarai MZ, Khan S, Sandal M.
europepmc +1 more source
Distinctive patterns of glucagon and incretin responses to oral and isoglycaemic intravenous glucose load in fibrocalculous pancreatic diabetes. [PDF]
Verma S +11 more
europepmc +1 more source
A randomised clinical trial testing the safety of and metabolic responses to short-term duodenal infusion of recombinant RORDEP1 in healthy men. [PDF]
Gæde J +9 more
europepmc +1 more source
A DYRK inhibitor ameliorates glucose homeostasis and increases incretin-producing cells in diabetic mice. [PDF]
Terasaki M +3 more
europepmc +1 more source
Clinical Potential of GIP in Type 2 Diabetes and Obesity. [PDF]
Nauck M +4 more
europepmc +1 more source
Incretin Mimetics as Potential Therapeutics for Concussion and Traumatic Brain Injury: A Narrative Review. [PDF]
Sipos S +3 more
europepmc +1 more source
Advantages of Skeletal Muscle Preservation in Settings of Weight Loss. [PDF]
Glass DJ.
europepmc +1 more source
Limited Comparative Evidence Between Metabolic Bariatric Surgery and Incretin-Based Pharmacotherapy for Weight Loss in Type 2 Diabetes: A Systematic Review and Meta-Analysis. [PDF]
Baniowdeh O +7 more
europepmc +1 more source
Tirzepatide for treatment of postbariatric hypoglycemia after Roux-en-Y gastric bypass: a report of 3 cases. [PDF]
Milosavljevic J +3 more
europepmc +1 more source
Adaptive islet biology and comprehensive incretin physiology: Emerging perspectives from Asia and Europe. [PDF]
Murakami T +5 more
europepmc +1 more source

